Catalyst Pharmaceuticals (CPRX) Amortizatization of Intangibles (2022 - 2026)

Catalyst Pharmaceuticals has reported Amortizatization of Intangibles for 5 years, with the latest figure at $9.7 million in Q1 2026.

• For the quarter ending Q1 2026, Amortizatization of Intangibles rose 16071.67% year-over-year to $9.7 million; the trailing twelve-month figure through Mar 2026 stood at $48.3 million (down 7.96% YoY), and the FY2025 full-year result was $37.5 million, changed 0.32% from the prior year.
• Amortizatization of Intangibles for Q1 2026 stood at $9.7 million, down from $37.3 million in the prior quarter.
• The five-year high for Amortizatization of Intangibles was $37.3 million in Q4 2025, with the low at -$535000.0 in Q4 2022.
• Historically, Amortizatization of Intangibles has averaged $8.3 million across 5 years, with a median of $4.4 million in 2023.
• Annual changes were most pronounced in 2024 — Amortizatization of Intangibles surged 21123.56% — and 2025, when it tumbled 93.67%.
• Catalyst Pharmaceuticals' Amortizatization of Intangibles stood at -$535000.0 in 2022, then surged by 67.48% to -$174000.0 in 2023, then surged by 21123.56% to $36.6 million in 2024, then climbed by 1.87% to $37.3 million in 2025, then sank by 73.96% to $9.7 million in 2026.
• The last three Amortizatization of Intangibles figures came in at $9.7 million (Q1 2026), $37.3 million (Q4 2025), and $500000.0 (Q3 2025), per Business Quant data.